summary
Introduced
05/10/2024
05/10/2024
In Committee
05/15/2024
05/15/2024
Crossed Over
09/10/2024
09/10/2024
Passed
Dead
01/03/2025
01/03/2025
Introduced Session
118th Congress
Bill Summary
AN ACT To prohibit contracting with certain biotechnology providers, and for other purposes.
AI Summary
This bill, the BIOSECURE Act, prohibits federal executive agencies from procuring or obtaining biotechnology equipment or services produced or provided by certain biotechnology companies of concern, as well as from entering into contracts with entities that use such equipment or services. It also prohibits the use of federal loan or grant funds for such purposes. The bill defines "biotechnology companies of concern" as those that are subject to the governance or control of foreign adversaries and pose risks to national security. The bill includes provisions for waiving the prohibitions in certain circumstances, such as for overseas healthcare services, and requires assessments, reporting, and guidance to implement the requirements. The bill does not authorize any additional funds to be appropriated for its implementation.
Committee Categories
Government Affairs, Military Affairs and Security
Sponsors (15)
Brad Wenstrup (R)*,
Stephanie Bice (R),
Don Davis (D),
Neal Dunn (R),
Anna Eshoo (D),
Josh Gottheimer (D),
Mark Green (R),
Ashley Hinson (R),
Raja Krishnamoorthi (D),
Darin LaHood (R),
John Moolenaar (R),
Seth Moulton (D),
Elissa Slotkin (D),
Elise Stefanik (R),
Tom Suozzi (D),
Last Action
Received in the Senate and Read twice and referred to the Committee on Homeland Security and Governmental Affairs. (on 09/10/2024)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/118th-congress/house-bill/8333/all-info |
| BillText | https://www.congress.gov/118/bills/hr8333/BILLS-118hr8333eh.pdf |
| BillText | https://www.congress.gov/118/bills/hr8333/BILLS-118hr8333ih.pdf |
Loading...